PUBLISHER: The Insight Partners | PRODUCT CODE: 1764968
PUBLISHER: The Insight Partners | PRODUCT CODE: 1764968
The Europe feed anticoccidials market was valued at US$ 234.76 million in 2023 and is expected to reach US$ 290.93 million by 2031; it is estimated to record a CAGR of 2.7% from 2023 to 2031.
Rise in Prevalence of Coccidiosis Drives Europe Feed Anticoccidials Market
Coccidiosis is a type of gastrointestinal infection in animals caused by coccidian protozoa. When an animal comes in contact with infected feces or tissue, the disease is transmitted. Diarrhea is the primary symptom of coccidiosis. The majority of poultry coccidiosis is highly host-specific and is caused by the genus Eimeria.
Coccidiosis directly infects animals and reduces their performance; it results in large economic losses. Owing to its direct impact on flock appearance and intestinal health, it is a major global concern in the poultry industry. The EW Nutrition Technical Team reports that coccidial illness costs the poultry sector more than US$ 14 billion a year and is a serious intestinal problem. Owing to damage to the intestinal cells, the disease results in decreased body weights, increased feed conversion rates, abnormalities in skin color, irregular flock sizes, and ultimately, death. According to DSM, across the world, yearly losses were estimated at more than US$ 3 billion due to coccidiosis in chickens and other avian species. Thus, coccidiosis prevention is becoming essential for producers, veterinary associations, and regulatory authorities of various countries.
According to the World Health Organization (WHO), the usage of antibiotics such as anticoccidial in animal feed as an additive can treat infections. There is a surge in the use of anticoccidials in feed by animal feed manufacturers to fight against infection in animals, overcome losses, and improve farm profitability. Thus, the rising prevalence of coccidiosis fuels the feed anticoccidial market growth.
Europe Feed Anticoccidials Market Overview
Ireland, Norway, Sweden, Denmark, Poland, Austria, Greece, Hungary, and the Netherlands are among the major countries in the rest of Europe feed anticoccidials market. These countries are witnessing increased adoption of anticoccidials due to rising livestock production and awareness about animal health. Factors such as rising demand for high-quality, disease-free meat products; and strict regulatory standards support the growth of the feed anticoccidials market in the region.
Europe Feed Anticoccidials Market Revenue and Forecast to 2031 (US$ Million)
Europe Feed Anticoccidials Market Segmentation
The Europe feed anticoccidials market is segmented based on type, form, livestock, and country. Based on type, the Europe feed anticoccidials market is segmented into ionophore, chemical anticoccidials, and chemical-ionophores. The ionophore segment held the largest market share in 2023.
In terms of form, the Europe feed anticoccidials market is bifurcated into dry and liquid. The dry segment held a larger market share in 2023.
Based on livestock, the Europe feed anticoccidials market is segmented into poultry, ruminants, swine, and others. The poultry segment held the largest market share in 2023.
Based on country, the Europe feed anticoccidials market is segmented into the UK, Germany, Spain, Italy, France, and the Rest of Europe. The Rest of Europe dominated the Europe feed anticoccidials market share in 2023.
Phibro Animal Health Corp, Zoetis Inc, Kemin Industries Inc, Elanco Animal Health Inc, Huvepharma EOOD, Impextraco NV, and Virbac SA. are some of the leading players operating in the Europe feed anticoccidials market.